Anticipated Stigma, Illness Identity, and Quality of Life in Male Hypogonadism
Condition(s) studied
Study summary
This study aims to systematically compare the levels of anticipated illness stigma and illness identity among men diagnosed with hypogonadism to those of men with other chronic endocrine conditions (e.g., diabetes mellitus, hypothyroidism, and hypertension). Furthermore, it examines whether these psychosocial variables predict quality-of-life deterioration specifically within the hypogonadism cohort.
Eligibility
Primary outcome measure(s)
- Chronic Illness Anticipated Stigma Scale (CIASS) Score — Baseline (Single session, day 1)
Measures anticipated stigma across three subscales (friends/family, work, healthcare workers) on a 5-point Likert scale. - Brief Illness Perception Questionnaire (Brief IPQ) Score — Baseline (Single session, day 1)
Assesses cognitive and emotional representations of illness. Higher total scores indicate a more threatening illness perception.
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Bingöl University Faculty of Physical Therapy and Rehabilitation | Bingoel | Turkey (Türkiye) | |
| Malatya Training and Research Hospital | Malatya | Turkey (Türkiye) |
More Hacettepe University trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07752511 on ClinicalTrials.gov ↗ ← All trials in Turkey